Profile picture

Doctor David Koeckerling

University Hospital Heidelberg, Heidelberg (Germany)
Follow
Logo ESC

Contributor content

Cardiotoxicity following BRAF and MEK inhibitor therapy: a meta-analysis of prevalence
Presentation
Cardiotoxicity following BRAF and MEK inhibitor therapy: a meta-analysis of prevalence
See more
Echocardiographic risk stratification in light chain and transthyretin amyloidosis: a meta-analysis
Presentation
Echocardiographic risk stratification in light chain and transthyretin amyloidosis: a meta-analysis
See more
Gut microbiome-derived metabolites as prognostic biomarkers in heart failure: a systematic review and meta-analysis
Presentation
Gut microbiome-derived metabolites as prognostic biomarkers in heart failure: a systematic review and meta-analysis
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources